Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Complex Cases from the Collection of Dr. Samuel Moschella
Description
In a session dedicated to complex cases presented by Dr. Samuel Moschella, attendees gathered to honor his 101-year legacy in addressing Hansen's disease (leprosy). The event kicked off by reflecting on Dr. Moschella's tremendous contributions to dermatology and his commitment to marginalized populations suffering from this often stigmatized illness. He first encountered leprosy while serving in Cuba in 1950, where he uncovered an epidemic on the naval base and sought mentorship to address the unrecognized cases. Over the years, Dr. Moschella trained thousands of residents through his seminar series on Hansen's disease and established a clinic that continues to this day. The presentation delved into the pathology of leprosy, including classifications, immunological responses, and treatment reactions, elucidating the complexities of the disease. The speaker highlighted the importance of understanding the psychological and social burdens that accompany leprosy, echoing Dr. Moschella's humanitarian focus on serving the underserved. The event underscored the ongoing challenge of eliminating leprosy as a public health issue, with high rates of new cases reported, reinforcing the necessity for collaboration and access to expert resources in the treatment of this multifaceted disease.
View moreConclusions
- Leprosy remains a significant public health issue, with over 183,000 new cases reported globally in 2023 and around 4 million individuals affected by the disease or its consequences.
- Dr. Samuel Moschella made substantial contributions to the understanding and treatment of Hansen's disease through his lifelong commitment to caring for marginalized populations.
- Stigmatization and discrimination are major barriers to the global elimination of leprosy, making it vital to improve awareness and understanding of the illness.
- The naming of the disease has significant implications for stigma; the shift from 'leprosy' to 'Hansen's disease' reflects an effort to reduce discrimination associated with the former term.
- Modern classification of Hansen's disease includes 'multibacillary' and 'paucibacillary' forms, with specific diagnostic criteria for each category.
- Leprosy has complex immunological and clinical manifestations, requiring detailed understanding for effective management and treatment.
- Reactions to treatment, specifically Type 1 and Type 2 reactions, are common and present unique challenges in the management of leprosy patients.
- The economic impact of leprosy is considerable, causing declines in productivity and quality of life, particularly among affected individuals from low-income backgrounds.
- Continued education and training in the management of Hansen's disease, as exemplified by Dr. Moschella's work, are essential for healthcare providers to improve patient outcomes.
- Bao PS, Darlong F, Timothy M, Kumar S, Abraham S, Kurian R. Disability adjusted working life years (DAWLYs) of leprosy affected persons in India. Indian J Med Res. 2013 May;137(5):907-10.
- Han XY, Seo YH, Sizer KC, Schoberle T, May GS, Spencer JS, et al. A New Mycobacterium Species Causing Diffuse Lepromatous Leprosy. Am J Clin Pathol. 2008;130:856-64.
- Deps P, Cruz A. Why we should stop using the word leprosy. Lancet Infect Dis 2020; 20: e75-78.
- L. Walker, Stephen; M. Sales, Anna; Ruth Butlin, C.; Shah, Mahesh; Maghanoy, Armi; M. Lambert, Saba; et al. (2017): ENLIST ENL Severity Scale .. PLOS Neglected Tropical Diseases. Journal contribution. https://doi.org/10.1371/journal.pntd.0005716.s001
- World Health Organization. Guidelines for the diagnosis, treatment and prevention of leprosy. New Delhi: World Health Organization, Regional Office for South-East Asia; 2017.